| Issuer | % of Class | Filed |
|---|---|---|
|
Provectus Biopharmaceuticals, Inc.
13D/A
Amendment 3
PVCT · 74373P108
|
11.6% |
7/22/2026
Event 6/30/2026
|
|
Provectus Biopharmaceuticals, Inc.
13D/A
Amendment 2
PVCT · 74373P108
|
10.6% |
12/1/2025
Event 11/26/2025
|
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.